Welcome to our dedicated page for Plum Acquisition SEC filings (Ticker: PLMJ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SEC filings for Plum Acquisition Corp. (NYSE: PLMJ) can feel like a maze: one day a Form S-1 trust balance update, the next a surprise 8-K announcing a potential business combination. For investors tracking a blank-check company, every footnote matters, yet the documents are dense and time-sensitive. Stock Titan captures every Plum Acquisition filing the moment it hits EDGAR and layers in AI-powered summaries so you immediately grasp dilution scenarios, redemption timelines and sponsor warrants without wading through hundreds of pages.
Whether you are Googling “Plum Acquisition insider trading Form 4 transactions” or need the latest “Plum Acquisition quarterly earnings report 10-Q filing” after a de-SPAC, our platform has you covered. Real-time alerts surface “Plum Acquisition Form 4 insider transactions real-time”, while interactive dashboards turn each “Plum Acquisition earnings report filing analysis” into clear trend lines. Prefer context over jargon? Our engine excels at “understanding Plum Acquisition SEC documents with AI,” linking every clause to prior submissions so you see changes in seconds.
You will also find a “Plum Acquisition annual report 10-K simplified,” “Plum Acquisition proxy statement executive compensation” breakdowns that spotlight sponsor promote economics, plus “Plum Acquisition 8-K material events explained” within minutes of release. From “Plum Acquisition executive stock transactions Form 4” to post-merger 10-Q footnotes, Stock Titan’s comprehensive coverage, real-time updates and expert commentary help you compare trust value to market price, monitor vote deadlines and make informed decisions faster.
Form 4 Overview: Maravai LifeSciences Holdings, Inc. (MRVI) disclosed that director John A. DeFord acquired 89,139 shares of Class A common stock on 16 June 2025.
Transaction details: The shares were granted as restricted stock units (RSUs) under the company’s 2020 Omnibus Incentive Plan at an assigned value of $2.16 per share. These RSUs will vest in full on the earlier of (i) one year from the grant date or (ii) the date of the 2026 annual shareholder meeting.
Post-transaction ownership: Following the award, DeFord’s beneficial ownership rises to 159,185 shares, all held directly.
Implications: A director increasing his stake—albeit via equity compensation—tends to align management and shareholder interests and can be interpreted as a vote of confidence in MRVI’s long-term prospects. Because the grant stems from an incentive plan rather than an open-market purchase, any cash outlay by the insider is not indicated in the filing.